Fulgent Genetics Inc. | Mutual Funds
Mutual Funds that own Fulgent Genetics Inc.
Vanguard Total Stock Market Index Fund
155,059
0.86%
0
0%
07/31/2018
Bridgeway Ultra Small Company Market Fund
78,100
0.43%
0
0.07%
12/31/2017
Royce Opportunity Select Fund
72,411
0.4%
4,500
0.6%
06/30/2018
DFA US Core Equity 2 Portfolio
25,976
0.14%
14,976
0%
04/30/2018
Vanguard Extended Market Index Fund
18,060
0.1%
0
0%
07/31/2018
Vanguard Institutional Total Stock Market Index Fund
16,903
0.09%
0
0%
07/31/2018
iShares Micro Cap ETF
14,630
0.08%
0
0.01%
09/06/2018
DFA US Core Equity 1 Portfolio
8,924
0.05%
8,924
0%
04/30/2018
Fidelity Nasdaq Composite Index
8,707
0.05%
0
0%
07/31/2018
DFA US Vector Equity Portfolio
2,810
0.02%
2,810
0%
04/30/2018
| Address |
4978 Santa Anita Avenue
Temple City California 91780
United States
|
|
Employees
|
- |
| Website |
http://www.fulgentgenetics.com |
| Updated |
07/08/2019 |
| Fulgent Genetics, Inc. is a technology company, which focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. The company was founded on May 13, 2016 and is headquartered in Temple City, CA. |
